Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations
European Journal of Neurology · 2026-06 · 33 (6)
DOI: 10.1111/ene.70669 ↗At a glance
Journal article in European Journal of Neurology, published online on 2026-06-23. Written by Constantina Rodica Popa and 10 co-authors. Institution: Lariboisière Hospital, CNVT-CERVCO, AP-HP, FHU NeuroVasc2030, DMU Neurosciences, Paris, France. Major MEDLINE topics: Hemangioma, Cavernous, Central Nervous System. 7 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background and Purpose Familial cerebral cavernous malformations (fCCM) may cause focal neurological deficits (FND) due to hemorrhagic or non‐hemorrhagic events and epileptic seizures (ES). With the widespread use of magnetic resonance imaging (MRI) and genetic testing, diagnosis is now frequently established at a presymptomatic stage, before any clinical manifestation. However, the subsequent risk of a first clinical event in these individuals remains poorly defined.
Methods
We conducted a cohort‐based analysis of retrospectively collected longitudinal data from 79 patients with fCCM who were asymptomatic at diagnosis (median age, 41.7 years) and managed in a national referral center.
Results
Over 649.6 patient‐years (median follow‐up, 4.0 years), 23 patients (29%) experienced a first clinical event. Post‐diagnostic event‐free survival was approximately 97% at 1 year, 79% at 5 years, and 69% at 10 years. Incidence rates for a first event were 35.4 per 1000 person‐years for any first event (FND or ES), 23.1 per 1000 person‐years for a first FND, and 15.4 per 1000 person‐years for a first ES. Male sex was independently associated with higher risk (HR 4.20; 95% CI, 1.60–11.04; p = 0.0036).
Conclusions
These data provide pragmatic post‐diagnostic risk estimates to guide counseling and surveillance in asymptomatic fCCM.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Lariboisière Hospital, CNVT-CERVCO, AP-HP, FHU NeuroVasc2030, DMU Neurosciences, Paris, France.
- Université Paris Cité, INSERM U1127, Paris Brain Institute, GenoVasc Team, Paris, France.
- Department of Medical Genetics, Molecular and Cellular Neurogenetics Unit, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France.
- Paris Brain Institute, INSERM UMR1127, GenoVasc Team, Sorbonne University, Paris, France.
ORCID profiles: Constantina Rodica Popa, Hugues Chabriat, Stéphanie Guey
Cite
APA
Popa, C. R., Hervé, D., Alili, N., Dubus, E., Taleb, A., Fernandes, F., Riant, F., Lasserve, E. T., Lambert, L., Chabriat, H., & Guey, S. (2026). Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations. European Journal of Neurology, 33(6). https://doi.org/10.1111/ene.70669
Vancouver
Popa CR, Hervé D, Alili N, Dubus E, Taleb A, Fernandes F, et al. Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations. European Journal of Neurology. 2026;33(6). doi:10.1111/ene.70669
BibTeX
@article{Popa2026,
author = {Popa, Constantina Rodica and Hervé, Dominique and Alili, Nassira and Dubus, Estelle and Taleb, Abbas and Fernandes, Fanny and Riant, Florence and Lasserve, Elisabeth Tournier and Lambert, Louis and Chabriat, Hugues and Guey, Stéphanie},
title = {Risk of Clinical Events in Presymptomatic Familial Cerebral Cavernous Malformations},
journal = {European Journal of Neurology},
year = {2026},
volume = {33},
number = {6},
doi = {10.1111/ene.70669}
}
EUVIMED